Ani Pharmaceuticals reported $27.64M in Trade Creditors for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Aerie Pharmaceuticals AERI:US $ 9.28M 1.4M
Ani Pharmaceuticals ANIP:US $ 27.64M 5.58M
Aurora Cannabis Inc ACB:CN C$ 8.57M 5.22M
Canopy Growth Corp WEED:CN C$ 64.65M 377K
Depomed DEPO:US $ 9.41M 0.89M
Eli Lilly And LLY:US $ 1659.3M 226M
Emergent Biosolutions EBS:US $ 106.2M 1.1M
Endo International Ordinary Shares ENDP:US $ 90.64M 10.36M
Heron Therapeutics HRTX:US $ 13.8M 5.58M
Hikma Pharmaceutical HIK:LN 255M 7M
Lannett LCI:US $ 28.57M 2.58M
Nektar Therapeutics NKTR:US $ 12.35M 0.27M
Novartis NVS:US $ 4969M 114M
Perrigo Ordinary Shares PRGO:US $ 490.4M 10.8M
Teva Pharmaceutical TEVA:IT 1.9B 151M
Teva Pharmaceutical Industries TEVA:US $ 1901M 151M